15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and leukotriene b4

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with leukotriene b4 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, C; Yamaguchi, RY; Ziboh, VA1
Hung, ND; Kim, MR; Sok, DE1

Other Studies

2 other study(ies) available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and leukotriene b4

ArticleYear
Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.
    Lipids, 1989, Volume: 24, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Docosahexaenoic Acids; Eicosapentaenoic Acid; Epidermis; Fatty Acids, Unsaturated; Fish Oils; Guinea Pigs; Leukotriene B4; Lipoxygenase Inhibitors; Male; Psoriasis; Tumor Cells, Cultured

1989
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
    British journal of pharmacology, 2011, Volume: 162, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosapentaenoic Acid; In Vitro Techniques; Inflammation Mediators; Injections, Intraperitoneal; Leukocytes; Leukotriene B4; Leukotriene C4; Lysophosphatidylcholines; Male; Mice; Mice, Inbred ICR; Oligopeptides; Oxidation-Reduction; Peritonitis; Structure-Activity Relationship; Zymosan

2011